CoChat

Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial

Open access
Ajdukiewicz, Katherine MB, Cartwright, Katharine E, Scarborough, Matthew, Mwambene, James B, Goodson, Patrick, Molyneux, Malcolm E, Zijlstra, Eduard E, French, Neil, Whitty, Christopher JM, Lalloo, David G · 2011 · The Lancet Infectious Diseases
Cited by 90

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary Background Southern Africa has a high incidence of bacterial meningitis in adults, often associated with HIV co-infection. Even with appropriate antibiotic therapy, mortality exceeds 50% and is not improved with corticosteroids. Glycerol adjuvant therapy reduced mortality and long-term morbidity (deafness) in bacterial meningitis in children and is being promoted. If similarly effective in adults, glycerol would provide a cheap, available adjuvant therapy in Africa. Methods Following a dose-finding study, we conducted a randomised double-blind placebo-controlled trial of oral glycerol in adults with bacterial meningitis. Patients with clinical and CSF findings suggestive of bacterial meningitis were randomised either to glycerol or an equivalent volume of sugar solution. The primary outcome was mortality at 40 days with secondary outcomes including disability and mortality restricted to pneumococcal disease. Findings 75ml glycerol QDS was best tolerated and was used for the main study. 265 patients were randomised to receive glycerol or placebo. The trial was stopped early on the advice of the Data and Safety Monitoring Board (DSMB) following a planned interim analysis. Mortality by day 40 was 61/125 (49%) in the placebo and 86/136 (69%) in the glycerol arms, Adjusted Odds Ratio 2·4 (95% CI 1·3-4·2 p0·003). There was no benefit from glycerol for death and disability by day 40 by intention to treat or in predefined subgroups. Two serious adverse events occurred possibly due to study drug. Interpretation Oral glycerol therapy did not improve mortality in adults with bacterial meningitis and cannot be recommended as a suitable adjuvant therapy in resource-poor settings with a high HIV prevalence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(10)70317-0

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 34

  1. Gordon, 2000, Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal, Clin Infect Dis, 31, 53, 10.1086/313910 · DOI · Paper page
  2. Scarborough, 2007, Corticosteroids for bacterial meningitis in adults in sub-saharan Africa, N Engl J Med, 357, 2441, 10.1056/NEJMoa065711 · DOI · Paper page
  3. Gordon, 2002, Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival, AIDS, 16, 1409, 10.1097/00002030-200207050-00013 · DOI
  4. de Gans, 2002, Dexamethasone in adults with bacterial meningitis, N Engl J Med, 347, 1549, 10.1056/NEJMoa021334 · DOI · Paper page
  5. Molyneux, 2002, Dexamethasone treatment in childhood bacterial meningitis in Malawi, Lancet, 360, 211, 10.1016/S0140-6736(02)09458-8 · DOI · Paper page
  6. van de Beek, 2010, Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data, Lancet Neurol, 9, 254, 10.1016/S1474-4422(10)70023-5 · DOI · Paper page
  7. Kilpi, 1995, Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis, Pediatr Infect Dis J, 14, 270, 10.1097/00006454-199504000-00005 · DOI · Paper page
  8. Peltola, 2007, Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial, Clin Infect Dis, 45, 1277, 10.1086/522534 · DOI · Paper page
  9. Sáez-Llorens, 2007, Glycerol and bacterial meningitis, Clin Infect Dis, 45, 1287, 10.1086/522536 · DOI
  10. Menger, 1971, Treatment with glycerol of cerebral oedema due to acute cerebral infarction, Lancet, 2, 993
  11. Gilsanz, 1975, Controlled trial of glycerol versus dexamethasone in the treatment of cerebral oedema in acute cerebral infarction, Lancet, 1, 1049, 10.1016/S0140-6736(75)91825-5 · DOI
  12. Bayer, 1987, Double-blind randomised trial of intravenous glycerol in acute stroke, Lancet, 1, 405, 10.1016/S0140-6736(87)90117-6 · DOI
  13. Yu, 1993, Treatment of acute cortical infarct with intravenous glycerol: a double-blind, placebo-controlled randomized trial, Stroke, 24, 1119, 10.1161/01.STR.24.8.1119 · DOI
  14. Cantore, 1964, Oral glycerol for the reduction of intracranial pressure, J Neurosurg, 21, 278, 10.3171/jns.1964.21.4.0278 · doi:10.3171/jns.1964.21.4.0278
  15. Wald, 1982, Oral glycerol for the treatment of traumatic intracranial hypertension, J Neurosurg, 56, 323, 10.3171/jns.1982.56.3.0323 · DOI
  16. Biestro, 1997, Osmotherapy for increased intracranial pressure: comparison between mannitol and glycerol, Acta Neurochir (Wien), 139, 725, 10.1007/BF01420045 · DOI
  17. Casey, 1963, Oral glycerol in glaucoma, BMJ, 2, 851, 10.1136/bmj.2.5361.851 · DOI
  18. Awasthi, 1965, Role of oral glycerol in glaucoma, Br J Ophthalmol, 49, 660, 10.1136/bjo.49.12.660 · DOI
  19. Righetti, 2004, Glycerol for acute stroke, Cochrane Database Syst Rev, 2
  20. Frank, 1981, Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use, Pharmacotherapy, 1, 147, 10.1002/j.1875-9114.1981.tb03562.x · DOI · Paper page
  21. Bingel, 2006, Acute encephalopathy due to glycerol over-consumption, J Neurol, 253, 125, 10.1007/s00415-005-0924-7 · doi:10.1007/s00415-005-0924-7
  22. Thornit, 2009, The effects of peroral glycerol on plasma osmolarity in diabetic patients and healthy individuals, Basic Clin Pharmacol Toxicol, 105, 289, 10.1111/j.1742-7843.2009.00462.x · doi:10.1111/j.1742-7843.2009.00462.x
  23. Singh, 2001, Reversible neurologic manifestation after glycerol: a short report, Neurology India, 49, 320
  24. Lewis, 2003, Prevalence and indicators of HIV and IADS among adults admitted to medical and surgical wards in Blantyre, Malawi, Trans R Soc Trop Med Hyg, 97, 91, 10.1016/S0035-9203(03)90035-6 · doi:10.1016/s0035-9203(03)90035-6
  25. Sankar, 2007, Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis, Indian Pediatrics, 44, 649
  26. Rottenberg, 1977, The effect of oral glycerol on intraventricular pressure in man, Neurology, 27, 600, 10.1212/WNL.27.7.600 · doi:10.1212/wnl.27.7.600
  27. Blaser, 2010, Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis, BMC Infect Dis, 10, 84, 10.1186/1471-2334-10-84 · DOI
  28. Coursin, 2004, Perioperative diabetic and hyperglycemic management issues, Critical Care Medicine, 32, S116, 10.1097/01.CCM.0000115623.52021.C0 · DOI
  29. Baker, 2006, Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease, Thorax, 61, 284, 10.1136/thx.2005.051029 · DOI · Paper page
  30. Donnelly, 1999, Glycerol-induced seizure: involvement of IL-1beta and glutamate, Neuroreport, 10, 1821, 10.1097/00001756-199906230-00004 · DOI
  31. Garcia-Sola, 1991, The immediate and longterm effects of mannitol and glycerol, Acta Neurochir, 109, 114, 10.1007/BF01403005 · doi:10.1007/bf01403005
  32. Nau, 1992, Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol, Eur J Clin Pharmacol, 42, 181, 10.1007/BF00278481 · DOI
  33. Pitlick, 1982, Effects of glycerol and hyperosmolality on intracranial pressure, Clin Pharmacol Ther, 31, 466, 10.1038/clpt.1982.61 · doi:10.1038/clpt.1982.61
  34. Guisado, 1975, Rebound phenomenon complicating cerebral dehydration with glycerol, J Neurosurg, 42, 226, 10.3171/jns.1975.42.2.0226 · doi:10.3171/jns.1975.42.2.0226

Cited by

See all 90

Metadata

Authors
Ajdukiewicz, K. M., Cartwright, K. E., Scarborough, M., Mwambene, J. B., Goodson, P., Molyneux, M. E., Zijlstra, E. E., French, N., Whitty, C. J., & Lalloo, D. G.
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2011-04
Volume
11
Issue
4
Pages
293-300
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2170414257
Cited by
90
References
3
FWCI
8.11
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s1473-3099(10)70317-0
The paper
Ajdukiewicz, K. M., Cartwright, K. E., Scarborough, M., Mwambene, J. B., Goodson, P., Molyneux, M. E., Zijlstra, E. E., French, N., Whitty, C. J., & Lalloo, D. G. (2011). Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(10)70317-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.